Target
Corticotropin-releasing factor-binding protein
Ligand
BDBM89613
Substrate
n/a
IC50
3850±n/a nM
Citation
 PubChem, PC Dose Response confirmation of uHTS hits for small molecule antagonists of the CRF-binding protein and CRF-R2 receptor complex in 384 well format PubChem Bioassay (2012)[AID] 
Target
Name:
Corticotropin-releasing factor-binding protein
Synonyms:
CRFBP | CRHBP | CRHBP_HUMAN | corticotropin releasing factor-binding protein
Type:
Enzyme Catalytic Domain
Mol. Mass.:
36143.95
Organism:
Homo sapiens (Human)
Description:
P24387
Residue:
322
Sequence:
MSPNFKLQCHFILIFLTALRGESRYLELREAADYDPFLLFSANLKRELAGEQPYRRALRCLDMLSLQGQFTFTADRPQLHCAAFFISEPEEFITIHYDQVSIDCQGGDFLKVFDGWILKGEKFPSSQDHPLPSAERYIDFCESGLSRRSIRSSQNVAMIFFRVHEPGNGFTLTIKTDPNLFPCNVISQTPNGKFTLVVPHQHRNCSFSIIYPVVIKISDLTLGHVNGLQLKKSSAGCEGIGDFVELLGGTGLDPSKMTPLADLCYPFHGPAQMKVGCDNTVVRMVSSGKHVNRVTFEYRQLEPYELENPNGNSIGEFCLSGL
  
Inhibitor
Name:
BDBM89613
Synonyms:
2-(2-bromophenyl)-5-[[1-(4-methylphenyl)-1,2,3,4-tetrazol-5-yl]sulfanylmethyl]-1,3,4-oxadiazole | 2-(2-bromophenyl)-5-[[1-(4-methylphenyl)tetrazol-5-yl]sulfanylmethyl]-1,3,4-oxadiazole | 2-(2-bromophenyl)-5-[[[1-(4-methylphenyl)-5-tetrazolyl]thio]methyl]-1,3,4-oxadiazole | 2-(2-bromophenyl)-5-[[[1-(p-tolyl)tetrazol-5-yl]thio]methyl]-1,3,4-oxadiazole | MLS000056702 | SMR000065083 | cid_2615763
Type:
Small organic molecule
Emp. Form.:
C17H13BrN6OS
Mol. Mass.:
429.294
SMILES:
Cc1ccc(cc1)-n1nnnc1SCc1nnc(o1)-c1ccccc1Br
Structure:
Search PDB for entries with ligand similarity: